Yüklüyor......
Revisiting 5α-reductase inhibitors and the risk of prostate cancer
The role of 5α-reductase inhibitors (5-ARI) in prostate cancer chemoprevention remains a controversy, as cancer prevention trials with 5-ARIs have shown a decreased incidence of low-grade prostate cancer but a potential increased risk in high-grade disease. Recent studies have shed light on the long...
Kaydedildi:
| Yayımlandı: | Nat Rev Urol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6358277/ https://ncbi.nlm.nih.gov/pubmed/29740116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41585-018-0018-9 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|